Brief: Balaxi Pharmaceuticals Received WHO-GMP Certification For Jadcherla Facility
31/08/2026 09:37
BRIEF-Balaxi Pharmaceuticals Received WHO-GMP Certification For Jadcherla Facility Aug 31 (Reuters) - Balaxi Pharmaceuticals Ltd BALX.NS:
BALAXI PHARMACEUTICALS LTD - RECEIVED WHO-GMP CERTIFICATION FOR ITS FACILITY AT JADCHERLA
Source text: [ID:]
Further company coverage: BALX.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Balaxi Pharmaceuticals
See all newsBrief: Balaxi Pharmaceuticals Received WHO-GMP Certification For Jadcherla Facility
India's Balaxi Pharma up after Africa, Latam expansion
Brief: Balaxi Pharmaceuticals Expands Global Reach With Hospital Partnerships In Angola
Brief: Balaxi Pharmaceuticals To Set Up Pharmaceutical Formulation Plant In A Phased Manner
Brief: Balaxi Pharmaceuticals Approves Set Up Of First Pharmaceutical Formulation Plant At Jadcherla, Hyderabad